Jonathan Kaufman
                About Jonathan
Jonathan focuses his practice on commercial and intellectual property transactions for Cooley’s public and private clients in the life sciences industry. Jonathan has helped to structure and negotiate a variety of collaboration and license agreements, with the goal of maximizing the value of a company’s products and technology assets.
Passions
Constructing and solving crossword puzzles
Visiting baseball stadiums
Spending time with his dog, Conan
Jonathan focuses his practice on commercial and intellectual property transactions for Cooley’s public and private clients in the life sciences industry.
Experience
- 
                    
Otsuka Pharmaceutical Announces Global Strategic Collaboration With Harbour BioMed
 - 
                    
Avenzo Therapeutics Announces Exclusive Global License Agreement With DualityBio
 - 
                    
Flare Therapeutics Announces Strategic Discovery Collaboration With Roche, Potentially Exceeding $1.8 Billion
 - 
                    
Kura Oncology Announces Global Strategic Collaboration With Kyowa Kirin
 - 
                    
BioAge Labs Announces $198 Million IPO
 
Admissions and credentials
- California
 
Get In Touch
Location
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.